Business Description
Rhythm Biosciences Ltd
ISIN : AU000000RHY2
Share Class Description:
ASX:RHY: Ordinary SharesDescription
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.63 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 5.2 | |||||
| 3-Year EPS without NRI Growth Rate | 21.4 | |||||
| 3-Year FCF Growth Rate | 2.4 | |||||
| 3-Year Book Growth Rate | -27.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.35 | |||||
| 9-Day RSI | 31.78 | |||||
| 14-Day RSI | 38.08 | |||||
| 6-1 Month Momentum % | 40.85 | |||||
| 12-1 Month Momentum % | -39.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.58 | |||||
| Quick Ratio | 1.58 | |||||
| Cash Ratio | 1.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 | |||||
| Shareholder Yield % | -11.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -257.62 | |||||
| ROA % | -184.33 | |||||
| ROIC % | -489.82 | |||||
| ROC (Joel Greenblatt) % | -1111.3 | |||||
| ROCE % | -252.23 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 29 | |||||
| EV-to-EBIT | -3.72 | |||||
| EV-to-EBITDA | -3.83 | |||||
| EV-to-FCF | -4.1 | |||||
| Earnings Yield (Greenblatt) % | -26.88 | |||||
| FCF Yield % | -23.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rhythm Biosciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.03 | ||
| Beta | 0.97 | ||
| Volatility % | 76.31 | ||
| 14-Day RSI | 38.08 | ||
| 14-Day ATR (A$) | 0.009001 | ||
| 20-Day SMA (A$) | 0.1119 | ||
| 12-1 Month Momentum % | -39.92 | ||
| 52-Week Range (A$) | 0.042 - 0.190909 | ||
| Shares Outstanding (Mil) | 283.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rhythm Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rhythm Biosciences Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rhythm Biosciences Ltd Frequently Asked Questions
What is Rhythm Biosciences Ltd(ASX:RHY)'s stock price today?
The current price of ASX:RHY is A$0.09. The 52 week high of ASX:RHY is A$0.19 and 52 week low is A$0.04.
When is next earnings date of Rhythm Biosciences Ltd(ASX:RHY)?
The next earnings date of Rhythm Biosciences Ltd(ASX:RHY) is .
Does Rhythm Biosciences Ltd(ASX:RHY) pay dividends? If so, how much?
Rhythm Biosciences Ltd(ASX:RHY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers